Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Beta-lactamase | 8 | 0 | 0 | 8 |
thioredoxin reductase | 13 | 0 | 0 | 13 |
aldehyde dehydrogenase 1 family, member A1 | 9 | 0 | 0 | 9 |
IDH1 | 6 | 0 | 0 | 6 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
dopamine D1 receptor | 2 | 0 | 0 | 2 |
GLS protein | 6 | 0 | 0 | 6 |
Thrombopoietin | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
ras-related protein Rab-9A | 5 | 0 | 0 | 5 |
histone acetyltransferase KAT2A isoform 1 | 7 | 0 | 0 | 7 |
lethal factor (plasmid) | 6 | 0 | 0 | 6 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 3 |
Spike glycoprotein | 7 | 0 | 1 | 8 |
ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
AR protein | 17 | 0 | 0 | 17 |
glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
geminin | 16 | 0 | 0 | 16 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 1 | 2 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
USP1 protein, partial | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
arylsulfatase A | 7 | 0 | 0 | 7 |
D(1A) dopamine receptor | 8 | 0 | 0 | 8 |
chromobox protein homolog 1 | 8 | 0 | 0 | 8 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 11 | 0 | 0 | 11 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
Solute carrier family 22 member 1 | 0 | 7 | 0 | 11 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 13 | 0 | 13 |
Multidrug resistance-associated protein 4 | 0 | 13 | 0 | 13 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
Bile salt export pump | 0 | 21 | 0 | 21 |
Albumin | 0 | 0 | 1 | 1 |
High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 7 | 2 | 12 |
Muscarinic acetylcholine receptor M4 | 0 | 6 | 1 | 9 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 1 | 6 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 2 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M5 | 0 | 6 | 1 | 9 |
Alpha-2A adrenergic receptor | 0 | 10 | 4 | 15 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 7 |
Muscarinic acetylcholine receptor M1 | 0 | 7 | 2 | 12 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 2 | 4 |
Alpha-2B adrenergic receptor | 0 | 9 | 3 | 13 |
Alpha-2C adrenergic receptor | 0 | 10 | 4 | 15 |
5-hydroxytryptamine receptor 1A | 0 | 11 | 5 | 17 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 2 | 9 |
D(1A) dopamine receptor | 0 | 3 | 1 | 4 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 12 | 2 | 14 |
Histamine H2 receptor | 0 | 3 | 2 | 5 |
Alpha-1D adrenergic receptor | 0 | 7 | 2 | 10 |
5-hydroxytryptamine receptor 2A | 0 | 8 | 1 | 9 |
5-hydroxytryptamine receptor 2C | 0 | 10 | 1 | 11 |
5-hydroxytryptamine receptor 1B | 0 | 7 | 2 | 9 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 3 | 1 | 4 |
Sodium-dependent serotonin transporter | 0 | 13 | 2 | 15 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 4 | 2 | 6 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 1 | 9 |
Alpha-1A adrenergic receptor | 0 | 6 | 2 | 8 |
Histamine H2 receptor | 3 | 2 | 1 | 8 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 12 | 2 | 14 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 2 | 3 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 12 | 0 | 12 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Ataxin-2 | 8 | 0 | 0 | 8 |
Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 2 | 3 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 3 | 2 | 5 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Phenylethanolamine N-methyltransferase | 0 | 3 | 0 | 3 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 6 | 1 | 7 |
Beta-2 adrenergic receptor | 0 | 2 | 3 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 5 | 0 | 0 | 5 |
Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 5 | 2 | 7 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 6 | 0 | 6 |
Type-1 angiotensin II receptor | 0 | 5 | 4 | 11 |
Type-2 angiotensin II receptor | 0 | 5 | 0 | 5 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
acetylcholinesterase | 7 | 0 | 0 | 7 |
RAR-related orphan receptor gamma | 10 | 0 | 0 | 10 |
GLI family zinc finger 3 | 9 | 0 | 0 | 9 |
thioredoxin glutathione reductase | 6 | 0 | 0 | 6 |
retinoic acid nuclear receptor alpha variant 1 | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 10 | 0 | 0 | 10 |
estrogen nuclear receptor alpha | 14 | 0 | 0 | 14 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
euchromatic histone-lysine N-methyltransferase 2 | 15 | 0 | 0 | 15 |
thyroid hormone receptor beta isoform 2 | 8 | 0 | 0 | 8 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 14 | 0 | 0 | 14 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 2 | 0 | 2 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
regulator of G-protein signaling 4 | 7 | 0 | 0 | 7 |
Beta-1 adrenergic receptor | 0 | 1 | 4 | 6 |
DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit pi | 6 | 1 | 3 | 10 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 7 | 6 | 13 |
Beta-1 adrenergic receptor | 0 | 6 | 6 | 12 |
Beta-3 adrenergic receptor | 0 | 2 | 6 | 8 |
Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit delta | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 1 | 3 | 10 |
Alpha-1A adrenergic receptor | 0 | 4 | 4 | 9 |
Alpha-1B adrenergic receptor | 0 | 3 | 3 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 1 | 3 | 10 |
GABA theta subunit | 6 | 1 | 3 | 10 |
Gamma-aminobutyric acid receptor subunit epsilon | 6 | 1 | 3 | 10 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
TDP1 protein | 12 | 0 | 0 | 12 |
estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 1, group I, member 3 | 9 | 0 | 0 | 9 |
progesterone receptor | 7 | 0 | 0 | 7 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 8 | 0 | 0 | 8 |
cystic fibrosis transmembrane conductance regulator | 0 | 2 | 0 | 2 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Chain A, Cruzipain | 5 | 0 | 0 | 5 |
phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1B3 | 0 | 5 | 0 | 6 |
Solute carrier organic anion transporter family member 1B1 | 0 | 5 | 0 | 6 |
ATAD5 protein, partial | 5 | 0 | 0 | 5 |
Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
Interferon beta | 7 | 0 | 0 | 7 |
Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
Integrin alpha-5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 0 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 6 | 0 | 6 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 2 |
Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
PPM1D protein | 4 | 0 | 0 | 4 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 3 |
Cytochrome P450 3A4 | 0 | 6 | 0 | 8 |
Androgen receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 7 | 0 | 8 |
Vitamin D3 receptor | 0 | 1 | 2 | 4 |
Cytochrome P450 2C9 | 0 | 6 | 0 | 7 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 2 | 0 | 2 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Choline O-acetyltransferase | 0 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 6 |
High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 5 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 2 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 3 | 0 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1A adrenergic receptor | 0 | 1 | 2 | 3 |
D | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
Alpha-2B adrenergic receptor | 0 | 3 | 1 | 4 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 3 | 1 | 4 |
Alpha-2A adrenergic receptor | 0 | 3 | 1 | 4 |
Alpha-1D adrenergic receptor | 0 | 4 | 1 | 5 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
Adenosine receptor A2b | 0 | 0 | 1 | 1 |
Adenosine receptor A2a | 0 | 1 | 1 | 3 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 2 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 3 | 1 | 5 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 3 | 1 | 5 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Nischarin | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 2 | 2 | 4 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 4 | 1 | 5 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 2 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
interleukin 8 | 3 | 0 | 0 | 3 |
PAX8 | 0 | 0 | 0 | 2 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
STAT3, partial | 0 | 1 | 0 | 1 |
Smad3 | 5 | 0 | 0 | 5 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
67.9K protein | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 8 | 0 | 0 | 8 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 6 | 0 | 10 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 5 | 1 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 5 | 1 | 1 | 7 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
GALC protein | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 4 | 1 | 5 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Luciferase | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
Histone H2A.x | 4 | 0 | 0 | 4 |
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
Glutamine synthetase | 0 | 1 | 0 | 1 |
Cytochrome P450 71B1 | 0 | 1 | 0 | 2 |
Glutamine synthetase | 0 | 1 | 0 | 1 |
2-dehydro-3-deoxyphosphooctonate aldolase | 0 | 1 | 0 | 1 |
EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
Polycomb protein EED | 0 | 1 | 0 | 1 |
Polycomb protein SUZ12 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EZH2 | 0 | 2 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 4 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | 0 | 0 | 1 | 1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | 0 | 0 | 1 | 1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | 0 | 0 | 1 | 1 |
G | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Squalene synthase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 3 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 3 | 1 | 4 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
endonuclease IV | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 4 | 2 | 7 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Transporter | 0 | 3 | 0 | 3 |
Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 2 | 0 | 2 |
Glutamate receptor 1 | 1 | 1 | 0 | 2 |
Glutamate receptor 3 | 1 | 1 | 0 | 2 |
Glutamate receptor 4 | 1 | 1 | 0 | 2 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 2 | 1 | 3 |
Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
Mu-type opioid receptor | 0 | 3 | 3 | 8 |
Delta-type opioid receptor | 0 | 4 | 3 | 9 |
Kappa-type opioid receptor | 0 | 3 | 2 | 8 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 1 | 4 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 3 |
Nitric oxide synthase, endothelial | 0 | 3 | 0 | 3 |
Nitric oxide synthase, endothelial | 0 | 4 | 0 | 4 |
Nitric oxide synthase, brain | 0 | 4 | 0 | 4 |
Nitric oxide synthase, brain | 0 | 4 | 0 | 4 |
Nitric oxide synthase, inducible | 0 | 3 | 0 | 3 |
Nitric oxide synthase, inducible | 0 | 4 | 0 | 4 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 2 | 0 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 1 | 2 |
Adenosine receptor A3 | 0 | 2 | 1 | 3 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
Adenosine receptor A2a | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
NS5 | 0 | 0 | 1 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Polymerase basic protein 2 | 0 | 0 | 1 | 1 |
RNA-directed RNA polymerase catalytic subunit | 0 | 0 | 1 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Adenosylhomocysteinase | 0 | 0 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 0 | 1 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
Chain A, ykoF | 0 | 0 | 1 | 1 |
Chain B, ykoF | 0 | 0 | 1 | 1 |
Chain A, ThiT | 0 | 0 | 1 | 1 |
Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
Transketolase | 0 | 0 | 1 | 1 |
Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
1-deoxy-D-xylulose-5-phosphate synthase | 0 | 0 | 1 | 1 |
1-deoxy-D-xylulose-5-phosphate synthase | 0 | 0 | 1 | 1 |
Ubiquitin-like modifier activating enzyme 2 | 0 | 1 | 0 | 1 |
SUMO1 activating enzyme subunit 1 | 0 | 1 | 0 | 1 |
hexokinase | 0 | 1 | 0 | 1 |
SUMO-conjugating enzyme UBC9 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Chain A, Histone deacetylase-like amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Histone deacetylase-like amidohydrolase | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Nrf2 | 1 | 0 | 0 | 1 |
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
Histone deacetylase | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 4E | 0 | 1 | 0 | 1 |
Gli1 | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
protein Wnt-3a precursor | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 3 | 0 | 2 | 1 | 6 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase JAK2 | 0 | 1 | 0 | 1 |
Bromodomain-containing protein 4 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 1 | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 1 |
Tubulin alpha-1A chain | 0 | 1 | 0 | 1 |
Tubulin beta chain | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Protein Tat | 0 | 0 | 1 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 0 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 0 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 1 | 6 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Apoptosis regulator BAX | 0 | 0 | 1 | 1 |
Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 2 | 2 | 7 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Histone deacetylase | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
Histone deacetylase-like amidohydrolase | 0 | 2 | 1 | 3 |
Histone deacetylase | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 2 | 7 |
Histone deacetylase 2 | 0 | 2 | 2 | 7 |
HD2 type histone deacetylase HDA106 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 1 | 6 |
Histone deacetylase 11 | 0 | 2 | 1 | 6 |
Carboxypeptidase B2 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 2 | 2 | 7 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
REST corepressor 3 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 2 | 2 | 7 |
Histone deacetylase 9 | 0 | 2 | 1 | 6 |
Histone deacetylase 5 | 0 | 2 | 1 | 6 |
Histone deacetylase | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |